TIDMIHC
RNS Number : 9375V
Inspiration Healthcare Group PLC
07 December 2023
Inspiration Healthcare Group plc
("Inspiration Healthcare", the "Company" or the "Group")
Directorate change
Strengthens Board with appointment of Roy Davis as Non-Executive
Director and Chair Designate
Inspiration Healthcare Group plc (AIM: IHC), the global medical
technology ("med tech") company pioneering best-in-class,
specialist neonatal intensive care medical devices, announces the
appointment of Gordon Roy Davis ("Roy") as a Non-Executive Director
and successor to Mark Abrahams. Mark has been Chair of the Board
since June 2015 following the reverse acquisition of Inditherm plc
by Inspiration Healthcare Ltd. Roy will become a Non-Executive
Director with effect from 25 January 2024 and Chair from 21 March
2024, when Mark Abrahams will step down from the Board of the
Company. On joining the Board, he will be appointed to the
Nominations Committee and will succeed Mark Abrahams as Chair of
this Committee.
Roy brings a wealth of commercial experience in medical devices
companies and has a proven track record of successfully scaling
companies and delivering substantial value for shareholders. He has
held leadership positions at a number of publicly quoted med tech
companies, including CEO of Optos plc, a leading retinal imaging
device manufacturer, from 2008 to 2016 until its sale to Nikon for
GBP259m in February 2015. From 2007 to 2008, Roy was CEO of Gyrus
Group plc, a leader in minimally invasive surgery and
visualisation, until its acquisition by Olympus Corporation in 2008
for $1.9 billion.
He is currently Non-Executive Chair at LungLife AI plc, Foster
and Freeman (the trading name of the Galton group of companies) and
Rair Health Ltd and was until recently, Non-Executive Chair at
Medica Group plc until its acquisition by IK Partners for GBP269
million earlier this year.
Mark Abrahams, Chair of Inspiration Healthcare said : "I am
delighted to welcome Roy to the Board. He has all the necessary
credentials to guide the Company through its next phase of
development and I look forward to working with him during the
transition to becoming Chair."
Neil Campbell, Chief Executive Officer of Inspiration Healthcare
said : "Roy's proven commercial track record, experience and
understanding of the med tech sector will be incredibly important
to the Company as we continue to deliver our strategy. His
knowledge of growing companies on the public markets will add
significant value and makes him an ideal successor to Mark
Abrahams. We look forward to capitalising on his expertise in our
space."
Roy Davis, Chair designate of Inspiration Healthcare said : " I
am delighted to be joining the Board of Inspiration Healthcare. The
Company is addressing a critical need, providing innovative,
lifesaving neonatal technologies and has the right products and
expertise to deliver significant long-term sustainable growth. I
look forward to working with Neil, the Executive team and the rest
of the Board in executing the strategy and delivering the next
stage of the Company's development."
In accordance with Schedule 2 (g) of the AIM Rules for
Companies, Gordon Roy Davis (aged 67 years) holds/has held the
following directorships/partnerships in the last five years:
Current directorships/partnerships Previous directorships/partnerships (last
five years)
LungLifeAI, Inc Medica Group plc
Rair Health Limited Edinburgh Molecular Imaging Limited
Galton Bidco Limited
Galton Midco Limited
Galton Topco Limited
Galton Tradeco Limited
In addition to the above, Roy Davis was a director of C-Quential
Limited until his resignation on 28 February 2001. The company
entered into a creditors voluntary liquidation on 11 February 2002
and was subsequently dissolved on 18 August 2007.
Gordon Roy Davis holds no ordinary shares in the Company.
There are no further disclosures to be made under Schedule 2(g)
of the AIM Rules for Companies.
Inspiration Healthcare Group Tel: +44 (0)330 175 0000
plc
Neil Campbell, Chief Executive
Officer
Liberum (Nominated Adviser & Tel: +44 (0)20 3100 2000
Broker)
Phil Walker, Richard Lindley,
Will King
Walbrook PR Ltd (Media and Investor Tel: +44 (0)20 7933 8780
Relations)
Anna Dunphy/Stephanie Cuthbert/
Louis Ashe-Jepson
About Inspiration Healthcare
Inspiration Healthcare (AIM: IHC) designs, manufactures and
markets pioneering medical technology. Based in the UK, the Company
specialises in neonatal intensive care medical devices, which are
addressing a critical need to help to save the lives and improve
the outcomes of patients, starting with the very first breaths of
life.
The Company has a broad portfolio of its own products and
complementary distributed products , for use in neonatal intensive
care designed to support even the most premature babies throughout
their hospital stay. Its own branded products range from highly
sophisticated capital equipment such as ventilators for life
support through to single-use disposables.
The Company sells its products directly to hospitals and
healthcare providers in the UK and Ireland, where it also
distributes a range of advanced medical technologies for infusion
therapy. In the rest of the world the Company has an established
network of distribution partners around the world giving access to
more than 75 countries.
The Company operates from its world-class Manufacturing and
Technology Centre in Croydon, South London and from its facility in
Hailsham, East Sussex.
Further information on Inspiration Healthcare can be found at
https://inspirationhealthcaregroup.com/ .
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
BOABRBDDGXGDGXL
(END) Dow Jones Newswires
December 07, 2023 02:00 ET (07:00 GMT)
Inspiration Healthcare (LSE:IHC)
Gráfica de Acción Histórica
De Mar 2024 a Abr 2024
Inspiration Healthcare (LSE:IHC)
Gráfica de Acción Histórica
De Abr 2023 a Abr 2024
